Yousef Mohammed Hawsawi

Dr. Yousef Hawsawi is a scientist specializing in molecular genomics and multi-omics, with a particular focus on breast cancer genomics and rare genetic disorders in the Saudi population. He brings over a decade of experience in whole-genome sequencing (WGS), whole-exome sequencing (WES), targeted gene panels, and medical bioinformatics data analysis. His clinical and research work integrates advanced genomic technologies with translational research to better understand disease mechanisms.

Dr. Hawsawi’s current research centers on identifying novel genetic variants associated with cancer and neurodegenerative diseases, as well as translating genomic and multi-omics discoveries into clinically relevant biomarkers and applications. Through his work, he contributes to advancing precision medicine and improving patient outcomes by bridging the gap between genomic research and clinical practice.

Whole-genome sequencing (WGS)

Whole-exome sequencing (WES)

Targeted gene panels

Bioinformatics data analysis

Cancer Genomics and multi-omics

Rare genomics disorders

Neurodegenerative disorders

Biomarker Discovery

Dr. Yousef M. Hawsawi, PhD, is an internationally trained scientist specializing in molecular genomics, multi-omics, and precision medicine. He has extensive academic, clinical, and translational research experience across leading institutions in the United Kingdom, Australia, and the United States. He earned his MSc with distinction from the University of Wales, Bangor, and a PhD in Molecular Medicine from the University of Leeds. During his doctoral training, he received the BACR Hamilton-Fairley Young Investigator Award in recognition of his contributions to cancer research, along with multiple excellence awards from Saudi authorities in the UK.

Dr. Hawsawi completed a postdoctoral fellowship at MD Anderson Cancer Center, where he worked within the Tamoxifen Research Group in breast medical oncology. He currently serves as a Scientist in Molecular Genomics and Multi-Omics at King Faisal Specialist Hospital & Research Centre (KFSH&RC), as well as an Adjunct Professor at Alfaisal University and a member of the BioGravity Community of Practice at the Saudi Space Agency (SSA). He also holds leadership roles in genomic diagnostics and research governance. He has authored more than 75 peer-reviewed publications, contributed to international book chapters, and secured major national research funding. His research focuses on cancer genomics, rare genetic disorders, and translational biomarker discovery, with the aim of advancing precision medicine and improving patient care.